Nasopharyngeal carcinomas: an update by Spano, J.-P., Busson, P., Atlan, D., Bourhis, J., Pignon, J.-P., Esteban, C., Armand, J.-P.

Get full text

Immune-related adverse events with immune checkpoint blockade: a comprehensive review by Michot, J.M, Bigenwald, C, Champiat, S, Collins, M, Carbonnel, F, Postel-Vinay, S, Berdelou, A, Varga, A, Bahleda, R, Hollebecque, A, Massard, C, Fuerea, A, Ribrag, V, Gazzah, A, Armand, J.P, Amellal, N, Angevin, E, Noel, N, Boutros, C, Mateus, C, Robert, C, Soria, J.C, Marabelle, A, Lambotte, O

Get full text

Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers by Soria, J.C, Massard, C, Magné, N, Bader, Th, Mansfield, C.D, Blay, J.Y, Bui, B.N, Moussy, A, Hermine, O, Armand, J.P

Get full text

Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy by Raymond, E, Faivre, S, Armand, J P

Get full text

L'échographie de contraste: un nouvel outil d'évaluation des thérapies ciblées by Lassau, N., Armand, J.-P.

Get full text

A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours by Boven, E, Massard, C, Armand, J P, Tillier, C, Hartog, V, Brega, N M, Countouriotis, A M, Ruiz-Garcia, A, Soria, J C

Get full text

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck by Pivot, X, Raymond, E, Laguerre, B, Degardin, M, Cals, L, Armand, J P, Lefebvre, J L, Gedouin, D, Ripoche, V, Kayitalire, L, Niyikiza, C, Johnson, R, Latz, J, Schneider, M

Get full text

Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials by RIVORY, L. P, HAAZ, M.-C, CANAL, P, LOKIEC, F, ARMAND, J.-P, ROBERT, J

Get full text

Irinotecan (CPT-11) High-Dose Escalation Using Intensive High-Dose Loperamide to Control Diarrhea by Abigerges, Dany, Armand, Jean-Pierre, Chabot, Guy G., Costa, Ligia Da, Fadel, Elie, Cote, Carole, Hérait, Patrice, Gandia, Daniel

Get full text

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck by Couteau, C, Chouaki, N, Leyvraz, S, Oulid-Aissa, D, Lebecq, A, Domenge, C, Groult, V, Bordessoule, S, Janot, F, Forni, M De, Armand, J-P

Get full text

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials by Chabot, G. G., Abigerges, D., Catimel, G., Culine, S., de Forni, M., Extra, J.-M., Mahjoubi, M., Hérait, P., Armand, J.-P., Bugat, R., Clavel, M., Marty, M. E.

Get full text

A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma by Rougier, P., Adenis, A., Ducreux, M., de Forni, M., Bonneterre, J., Dembak, M., Clouet, P., Lebecq, A., Baille, P., Lefresne-Soulas, F., Blanc, C., Armand, J.P.

Get full text

Non-randomised phase II trials of drug combinations: often meaningless, sometimes misleading. Are there alternative strategies? by Van Glabbeke, M., Steward, W., Armand, J.P.

Get full text

Procarbazine in haematology: an old drug with a new life? by Massoud, M, Armand, J.P, Ribrag, V

Get full text

Inhibiteurs de tyrosine kinase ciblant le VEGFR by Loriot, Y., Massard, C., Armand, J.-P.

Get full text

Molecular Detection of Telomerase-positive Circulating Epithelial Cells in Metastatic Breast Cancer Patients by SORIA, J.-C, GAUTHIER, L. R, RAYMOND, E, GRANOTIER, C, MORAT, L, ARMAND, J.-P, BOUSSIN, F. D, SABATIER, L

Get full text

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC) by Monnet, I, Brienza, S, Hugret, F, Voisin, S, Gastiaburu, J, Saltiel, J.C, Soulié, P, Armand, J.P, Cvitkovic, E, de Cremoux, H

Get full text

Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherap... by Fizazi, K, Caliandro, R, Soulié, P, Fandi, A, Daniel, C, Bedin, A, Doubre, H, Viala, J, Rodier, J.-M, Trandafir, L, Le Chevalier, T, Cvitkovic, E, Armand, J.-P, Ruffié, P

Get full text

Phase II trial of chemotherapy with 5‐fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of... by Taamma, Abdelkrim, Fandi, Abdelrahim, Azli, Nacer, Wibault, Pierre, Chouaki, Nadia, Hasbini, Ali, Couteau, Corinne, Armand, Jean‐Pierre, Cvitkovic, Esteban

Get full text

Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors by Massard, C., Salazar, R., Armand, J. P., Majem, M., Deutsch, E., García, M., Oaknin, A., Fernández-García, E. M., Soto, A., Soria, J. C.

Get full text